Neuroligin Function in vivo: Implications for Autism and Mental Retardation

Neuroligin 体内功能:对自闭症和智力迟钝的影响

基本信息

  • 批准号:
    7573138
  • 负责人:
  • 金额:
    $ 39.25万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-12-23 至 2013-11-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Loss-of-function mutations in members of the neuroligin (NL) family of trans-synaptic cell adhesion molecules have been implicated in human autism and mental retardation. Animal models of autism have been severely limited, but these human genetic findings provide a novel path to develop bona fide mouse models of at least a subtype of human autism or mental retardation. NLs are postsynaptic transmembrane proteins that bind presynaptic beta-neurexins to induce formation of excitatory and inhibitory synapses and to control excitatory/inhibitory (E/I) synapse balance in cultured neurons. Alterations in E/I balance have been proposed as important in pathogenesis of autism and mental retardation. The precise role of NL in vivo and in neurobehavioral abnormalities in autism and mental retardation, however, remains to be determined. We will determine the role of neuroligin in vivo using electrophysiologic and behavioral characterization of NL knockout, human disease mutation knockin, and, in follow-up studies, conditional knockout mice. The driving hypothesis is that mice deficient in NL genes, or carrying known disease-linked mutations in NL, will exhibit behavioral differences consistent with those in human autism or mental retardation, and that these behavioral differences will be associated with specific abnormalities in E/I balance or synaptic function in cortical circuits in vivo. The following specific aims will be addressed: 1. To determine whether NL3 disease-linked mutation or deletion of NL3 result in autism and mental retardation-related behavioral abnormalities. 2. To determine whether deletion of NL3 or NL3 disease-linked mutations result in altered excitatory and inhibitory synaptic connectivity and function. 3. To determine whether deletion of NL3 or NL3 disease-linked mutations alter the threshold for inducing NMDA-receptor-dependent synaptic plasticity in the hippocampus. PUBLIC HEALTH RELEVANCE: Autism spectrum disorder and mental retardation are common, debilitating disorders involving social interaction or cognitive function with clinical overlap in a subset of patients. Recently, loss-of-function mutations in members of the Neuroligin family of trans-synaptic cell adhesion molecules have been implicated in human autism and mental retardation. Mice with genetic alterations of Neuroligin will be characterized as potential animal models of autism and mental retardation in an effort to better understand the cause and treatment of these debilitating disorders.
描述(由申请人提供):跨突触细胞粘附分子的神经肽(NL)家族成员的功能丧失突变与人类自闭症和智力迟钝有关。自闭症动物模型受到严重限制,但这些人类遗传学发现为开发至少一种人类自闭症或智力迟钝亚型的真正小鼠模型提供了一条新途径。 NL 是突触后跨膜蛋白,可结合突触前 β-神经毒素,诱导兴奋性和抑制性突触的形成,并控制培养神经元中的兴奋性/抑制性 (E/I) 突触平衡。 E/I 平衡的改变被认为在自闭症和智力低下的发病机制中很重要。然而,NL 在体内以及在自闭症和精神发育迟滞的神经行为异常中的确切作用仍有待确定。我们将利用 NL 敲除、人类疾病突变敲除以及后续研究中条件敲除小鼠的电生理和行为特征来确定 Neuroligin 在体内的作用。驱动假设是,缺乏 NL 基因或携带已知与疾病相关的 NL 突变的小鼠将表现出与人类自闭症或智力迟钝一致的行为差异,并且这些行为差异将与体内皮质回路中 E/I 平衡或突触功能的特定异常相关。将解决以下具体目标: 1. 确定 NL3 疾病相关突变或 NL3 缺失是否会导致自闭症和智力低下相关的行为异常。 2. 确定NL3或NL3疾病相关突变的缺失是否会导致兴奋性和抑制性突触连接和功能的改变。 3. 确定NL3或NL3疾病相关突变的缺失是否会改变海马中诱导NMDA受体依赖性突触可塑性的阈值。公共卫生相关性:自闭症谱系障碍和精神发育迟滞是常见的、使人衰弱的疾病,涉及社会互动或认知功能,在一部分患者中具有临床重叠。最近,跨突触细胞粘附分子 Neuroligin 家族成员的功能丧失突变与人类自闭症和智力低下有关。具有 Neuroligin 基因改变的小鼠将被定性为潜在的自闭症和智力迟钝动物模型,以更好地了解这些使人衰弱的疾病的原因和治疗方法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Craig M Powell其他文献

Craig M Powell的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Craig M Powell', 18)}}的其他基金

Preliminary Functional Studies of an Understudied NDD Gene in Mice
小鼠中待研究的 NDD 基因的初步功能研究
  • 批准号:
    10726239
  • 财政年份:
    2023
  • 资助金额:
    $ 39.25万
  • 项目类别:
Molecular and Cellular Basis of Neurodevelopmental Disorders
神经发育障碍的分子和细胞基础
  • 批准号:
    10347351
  • 财政年份:
    2020
  • 资助金额:
    $ 39.25万
  • 项目类别:
Molecular and Cellular Basis of Neurodevelopmental Disorders
神经发育障碍的分子和细胞基础
  • 批准号:
    10553679
  • 财政年份:
    2020
  • 资助金额:
    $ 39.25万
  • 项目类别:
Striatal synaptic Abnormalities in Models of Autism
自闭症模型中的纹状体突触异常
  • 批准号:
    8235641
  • 财政年份:
    2012
  • 资助金额:
    $ 39.25万
  • 项目类别:
Striatal synaptic Abnormalities in Models of Autism
自闭症模型中的纹状体突触异常
  • 批准号:
    8514726
  • 财政年份:
    2012
  • 资助金额:
    $ 39.25万
  • 项目类别:
Striatal synaptic Abnormalities in Models of Autism
自闭症模型中的纹状体突触异常
  • 批准号:
    8848888
  • 财政年份:
    2012
  • 资助金额:
    $ 39.25万
  • 项目类别:
Striatal synaptic Abnormalities in Models of Autism
自闭症模型中的纹状体突触异常
  • 批准号:
    8662796
  • 财政年份:
    2012
  • 资助金额:
    $ 39.25万
  • 项目类别:
Novel Genetic Models of Autism
自闭症的新遗传模型
  • 批准号:
    8160437
  • 财政年份:
    2011
  • 资助金额:
    $ 39.25万
  • 项目类别:
Novel Genetic Models of Autism
自闭症的新遗传模型
  • 批准号:
    8306800
  • 财政年份:
    2011
  • 资助金额:
    $ 39.25万
  • 项目类别:
Novel Genetic Models of Autism
自闭症的新遗传模型
  • 批准号:
    8725214
  • 财政年份:
    2011
  • 资助金额:
    $ 39.25万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 39.25万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.25万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 39.25万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.25万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 39.25万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 39.25万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.25万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 39.25万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 39.25万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.25万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了